Julie Marie Vose, MD

  • 41254 Citations
  • 92 h-Index
1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Julie Marie Vose is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 40 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.



Cerny, R., Issenberg, P., Bresnick, E., Kuszynski, C. A., Christman, J., Lynch, J. C., Tempero, M., Nagel, D., Smith, D. L., Kuszynski, C. A., Pour, P., Vose, J. M., Hollingsworth, T., Rogan, E. G., Bridge, J. A., Sherman, S., Lawson, T. A., Johnson, D. R., Kessinger, M. A., Cowan, K. H., Hollingsworth, T., Rogan, E. G., Bridge, J. A., Volsky, D., Conrad, R., Nagel, D., Rhode, S., Ruddon, R., Ramspott, E., Pour, P., Gmeiner, W., Lewis, R. E., Borgstahl, G. E., Caplan, S. H., Band, H., Ganti, A. K. P., Meza, J. L., Black, J. D., Guda, B., Wang, J., Semerad, C. L. & Wang, G.

National Institutes of Health


Project: Research project

  • FLT-PET/CT for Therapy Monitoring of DLBCL

    Fayad, L., Quon, A. & Vose, J. M.

    National Institutes of Health


    Project: Research project

  • Research Output

    Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics

    Torka, P., Kothari, S. K., Sundaram, S., Li, S., Medeiros, L. J., Ayers, E. C., Landsburg, D. J., Bond, D. A., Maddocks, K. J., Giri, A., Hess, B., Pham, L. Q., Advani, R., Liu, Y., Barta, S. K., Vose, J. M., Churnetski, M. C., Cohen, J. B., Burkart, M., Karmali, R. & 12 others, Zurko, J., Mehta, A., Olszewski, A. J., Lee, S., Hill, B. T., Burns, T. F., Lansigan, F., Rabinovich, E., Peace, D., Groman, A., Attwood, K. & Hernandez-Ilizaliturri, F. J., Jan 28 2020, In : Blood Advances. 4, 2, p. 253-262 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas

    Zhang, X., Bi, C., Lu, T., Zhang, W., Yue, T., Wang, C., Tian, T., Zhang, X., Huang, Y., Lunning, M., Hao, X., Brown, L. E., Devine, W. G., Vose, J., Porco, J. A. & Fu, K., Jan 1 2020, In : Leukemia. 34, 1, p. 138-150 13 p.

    Research output: Contribution to journalArticle

  • Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma

    LaCasce, A. S., Bociek, R. G., Sawas, A., Caimi, P., Agura, E., Matous, J., Ansell, S. M., Crosswell, H. E., Islas-Ohlmayer, M., Behler, C., Cheung, E., Forero-Torres, A., Vose, J., O’Connor, O. A., Josephson, N., Wang, Y. & Advani, R., Jan 1 2020, (Accepted/In press) In : British Journal of Haematology.

    Research output: Contribution to journalLetter

    Open Access
    1 Scopus citations

    ALK-positive anaplastic large-cell lymphoma in adults: An individual patient data pooled analysis of 263 patients

    Sibon, D., Nguyen, D. P., Schmitz, N., Suzuki, R., Feldman, A. L., Gressin, R., Lamant, L., Weisenburger, D. D., Rosenwald, A., Nakamura, S., Ziepert, M., Maurer, M. J., Bast, M., Armitage, J. O., Vose, J. M., Tilly, H., Jais, J. P. & Savage, K. J., Jan 1 2019, In : Haematologica. 104, 12, p. E562-E565

    Research output: Contribution to journalLetter

    Open Access
    4 Scopus citations

    A novel approach to eliminate therapy-resistant mantle cell lymphoma: synergistic effects of Vorinostat with Palbociclib

    Chaturvedi, N. K., Hatch, N. D., Sutton, G. L., Kling, M., Vose, J. M. & Joshi, S. S., Apr 16 2019, In : Leukemia and Lymphoma. 60, 5, p. 1214-1223 10 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations